Cited by 250Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline

Open access
Peters, Anne L., Ahmann, Andrew J., Battelino, Tadej, Evert, Alison, Hirsch, Irl B., Murad, M. Hassan, Winter, William E., Wolpert, Howard·2016·The Journal of Clinical Endocrinology & Metabolism

Abstract

OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline. EVIDENCE: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2016-2534

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intensive insulin management education programs that include nutrition therapy improve A1C and quality of life.

    “Intensive insulin management education programs that include nutrition therapy have been shown to improve A1C (9,264,268,271 -273) and quality of life (9,274).”

    From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [272]

    The Continuous subcutaneous insulin infusion section reports improved A1C after a teaching program and after use of CSII with a curriculum adapted from Dose Adjustment for Normal Eating. The guideline does not establish that nutrition therapy within an education program produced those improvements, or that such a program improved quality of life; its Introduction discusses quality of life as a goal of diabetes technology. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Evidence suggests insulin pump therapy may reduce diabetic ketoacidosis risk and diabetes complications, particularly retinopathy and peripheral neuropathy in youth, compared with multiple daily injections.

    “There is also evidence that insulin pump therapy may reduce DKA risk (182,186) and diabetes complications, particularly retinopathy and peripheral neuropathy in youth, compared with MDI (169).”

    From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [169]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. American Diabetes Association. 7. Approaches to glycemic treat- ment. Diabetes Care. 2015;38:S41-S48.
  2. Golden SH, Brown T, Yeh HC, et al. AHRQ Comparative Effec- tiveness Reviews. Methods for Insulin Delivery and Glucose Mon- itoring: Comparative Effectiveness Review No. 57. Rockville, MD: Agency for Healthcare Research and Quality; 2012.

Cited by

Sorted by citations

Authors
Peters, A. L., Ahmann, A. J., Battelino, T., Evert, A., Hirsch, I. B., Murad, M. H., Winter, W. E., & Wolpert, H.
Affiliations
University of Southern California (US)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2016-11
Volume
101
Issue
11
Pages
3922-3937
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2518284272
Cited by
250
References
115
Citations by year
2026: 13 · 2025: 24 · 2024: 17 · 2023: 19 · 2022: 23 · 2021: 39 · 2020: 31 · 2019: 32 · 2018: 31 · 2017: 19 · 2016: 2
FWCI
28.12
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
diabetes technology, insulin pump therapy, continuous glucose monitoring, adults with diabetes, diabetes management, clinical guidelines
MeSH terms
Adult, Blood Glucose, Combined Modality Therapy, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diet, Diabetic, Endocrinology, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, International Agencies, Patient Education as Topic, Societies, Scientific, Exercise, Drug Monitoring, Monitoring, Ambulatory, Evidence-Based Medicine, Consensus, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review